HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 2005-0558v1 24/6/1583    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chung, S. Articles by Kim, K.-S. Search for Related Content PubMed PubMed Citation Articles by Chung, S. Articles by Kim, K.-S.

TISSUE-SPECIFIC STEM CELLS

Neural Precursors Derived from Embryonic Stem Cells, but Not Those from Fetal Ventral Mesencephalon, Maintain the Potential to Differentiate into Dopaminergic Neurons After Expansion In Vitro

^a Udall Parkinson’s Disease Research Center of Excellence, McLean Hospital/Harvard Medical School, Belmont, Massachusetts, USA;
^b Molecular Neurobiology Laboratories, McLean Hospital/Harvard Medical School, Belmont, Massachusetts, USA;
^c Department of Neurology, The University of Chicago, Chicago, Illinois, USA;
^d Neuroregeneration Laboratories, McLean Hospital/Harvard Medical School, Belmont, Massachusetts, USA

Key Words. Differentiation • Stem cell expansion • Neural stem cell • Embryonic stem cell

Correspondence: Kwang-Soo Kim, Ph.D., MRC 216, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, Massachusetts 02178, USA. Telephone: 617-855-2024; Fax: 617-855-3479; e-mail: kskim{at}mclean.harvard.edu

Received November 15, 2005; accepted for publication March 13, 2006.

Neural precursors (NPs) derived from ventral mesencephalon (VM) normally generate dopaminergic (DA) neurons in vivo but lose their potential to differentiate into DA neurons during mitogenic expansion in vitro, hampering their efficient use as a transplantable and experimental cell source. Because embryonic stem (ES) cell-derived NPs (ES NP) do not go through the same maturation process during in vitro expansion, we hypothesized that expanded ES NPs may maintain their potential to differentiate into DA neurons. To address this, we expanded NPs derived from mouse embryonic day-12.5 (E12.5) VM or ES cells and compared their developmental properties. Interestingly, expanded ES NPs fully sustain their ability to differentiate to the neuronal as well as to the DA fate. In sharp contrast, VM NPs almost completely lost their ability to become neurons and tyrosine hydroxylase-positive (TH⁺) neurons after expansion. Expanded ES NP-derived TH⁺ neurons coexpressed additional DA markers such as dopa decarboxylase and DAT (dopamine transporter). Furthermore, they also expressed other midbrain DA markers, including Nurr1 and Pitx3, and released significant amounts of DA. We also found that these ES NPs can be cryopreserved without losing their proliferative and developmental potential. Finally, we tested the in vivo characteristics of the expanded NPs derived from J1 ES cells with low passage number. When transplanted into the mouse striatum, the expanded NPs as well as control NPs efficiently generated DA neurons expressing mature DA markers, with approximately 10% tumor formation in both cases. We conclude that ES NPs maintain their developmental potential during in vitro expansion, whereas mouse E12.5 VM NPs do not.

This article has been cited by other articles:

				T. C. Dinger, S. Eckardt, S. W. Choi, G. Camarero, S. Kurosaka, V. Hornich, K. J. McLaughlin, and A. M. Muller Androgenetic Embryonic Stem Cells Form Neural Progenitor Cells In Vivo and In Vitro Stem Cells, June 1, 2008; 26(6): 1474 - 1483. [Abstract] [Full Text] [PDF]

				L. Roybon, T. Hjalt, N. S. Christophersen, J.-Y. Li, and P. Brundin Effects on Differentiation of Embryonic Ventral Midbrain Progenitors by Lmx1a, Msx1, Ngn2, and Pitx3 J. Neurosci., April 2, 2008; 28(14): 3644 - 3656. [Abstract] [Full Text] [PDF]

				F. E. O'Keeffe, S. A. Scott, P. Tyers, G. W. O'Keeffe, J. W. Dalley, R. Zufferey, and M. A. Caldwell Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease Brain, March 1, 2008; 131(3): 630 - 641. [Abstract] [Full Text] [PDF]

				A. K. Shetty and B. Hattiangady Concise Review: Prospects of Stem Cell Therapy for Temporal Lobe Epilepsy Stem Cells, October 1, 2007; 25(10): 2396 - 2407. [Abstract] [Full Text] [PDF]

				J. Pruszak, K.-C. Sonntag, M. H. Aung, R. Sanchez-Pernaute, and O. Isacson Markers and Methods for Cell Sorting of Human Embryonic Stem Cell-Derived Neural Cell Populations Stem Cells, September 1, 2007; 25(9): 2257 - 2268. [Abstract] [Full Text] [PDF]

				P. Soundararajan, B. W. Lindsey, C. Leopold, and V. F. Rafuse Easy and Rapid Differentiation of Embryonic Stem Cells into Functional Motoneurons Using Sonic Hedgehog-Producing Cells Stem Cells, July 1, 2007; 25(7): 1697 - 1706. [Abstract] [Full Text] [PDF]

				S. Shin, Y. Sun, Y. Liu, H. Khaner, S. Svant, J. Cai, Q. X. Xu, B. P. Davidson, S. L. Stice, A. K. Smith, et al. Whole Genome Analysis of Human Neural Stem Cells Derived from Embryonic Stem Cells and Stem and Progenitor Cells Isolated from Fetal Tissue Stem Cells, May 1, 2007; 25(5): 1298 - 1306. [Abstract] [Full Text] [PDF]